| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $2,372,823,065 | 10,568,897 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,031,849,222 | 30,739,020 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 004225108 | $659,462,348 | 42,877,916 | SOLE | |||
| Summit Therapeutics Inc. | COM | 86627T108 | $534,904,544 | 24,424,865 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $419,047,490 | 1,974,590 | SOLE | |||
| Revolution Medicines, Inc. | COM | 76155X100 | $343,258,232 | 7,569,090 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $335,210,395 | 6,398,366 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $322,362,014 | 4,415,918 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $283,787,320 | 5,995,929 | SOLE | |||
| Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | $212,721,095 | 9,399,960 | SOLE | |||
| Edgewise Therapeutics, Inc. | COM | 28036F105 | $155,871,175 | 5,840,059 | SOLE | |||
| Replimune Group, Inc. | COM | 76029N106 | $121,056,883 | 11,045,336 | SOLE | |||
| Alkermes plc | SHS | G01767105 | $117,047,210 | 4,181,751 | SOLE | |||
| Denali Therapeutics Inc. | COM | 24823R105 | $108,704,275 | 3,731,695 | SOLE | |||
| Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | $98,325,495 | 42,850,000 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $87,553,133 | 1,576,114 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $87,231,349 | 3,882,125 | SOLE | |||
| Entrada Therapeutics, Inc. | COM | 29384C108 | $77,755,788 | 4,865,819 | SOLE | |||
| Immatics N.V. | SHS | N44445109 | $73,519,171 | 6,443,398 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $71,566,664 | 27,525,640 | SOLE | |||
| Kiniksa Pharmaceuticals International, plc | ORD SHS CL A | G52694109 | $70,429,892 | 2,818,323 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $67,686,807 | 4,092,310 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $60,660,920 | 111,904 | SOLE | |||
| Stoke Therapeutics, Inc. | COM | 86150R107 | $53,688,164 | 4,368,443 | SOLE | |||
| Immunocore Holdings plc | ADS | 45258D105 | $47,171,849 | 1,515,318 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $45,180,379 | 17,310,490 | SOLE | |||
| Sera Prognostics, Inc. | CLASS A COM | 81749D107 | $42,388,312 | 5,434,399 | SOLE | |||
| CRISPR Therapeutics AG | NAMEN AKT | H17182108 | $39,607,664 | 843,075 | SOLE | |||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | $39,121,142 | 993,679 | SOLE | |||
| Immunovant, Inc. | COM | 45258J102 | $34,936,439 | 1,225,410 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $33,890,570 | 19,477,339 | SOLE | |||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | $33,648,057 | 1,062,123 | SOLE | |||
| Roivant Sciences Ltd. | SHS | G76279101 | $32,297,183 | 2,798,716 | SOLE | |||
| Akero Therapeutics, Inc. | COM | 00973Y108 | $31,475,283 | 1,097,082 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $30,933,086 | 169,934 | SOLE | |||
| Celcuity Inc. | COM | 15102K100 | $27,955,922 | 1,874,978 | SOLE | |||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $26,055,304 | 4,916,095 | SOLE | |||
| Dyne Therapeutics, Inc. | COM | 26818M108 | $24,141,688 | 672,096 | SOLE | |||
| Biomea Fusion, Inc. | COM | 09077A106 | $21,300,385 | 2,108,949 | SOLE | |||
| Bicara Therapeutics Inc. | COM | 055477103 | $21,224,992 | 833,333 | SOLE | |||
| Prelude Therapeutics Inc. | COM | 74065P101 | $20,956,316 | 10,123,824 | SOLE | |||
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | $19,622,576 | 1,227,178 | SOLE | |||
| Neurogene Inc. | COM | 64135M105 | $19,134,389 | 456,015 | SOLE | |||
| Praxis Precision Medicines, Inc. | COM | 74006W207 | $18,591,462 | 323,105 | SOLE | |||
| Alumis Inc. | COM | 022307102 | $16,687,500 | 1,562,500 | SOLE | |||
| Merus N.V. | COM | N5749R100 | $14,988,000 | 300,000 | SOLE | |||
| TScan Therapeutics, Inc. | COM | 89854M101 | $13,868,264 | 2,784,792 | SOLE | |||
| Neumora Therapeutics, Inc. | COM | 640979100 | $13,667,066 | 1,034,600 | SOLE | |||
| Xencor, Inc. | COM | 98401F105 | $13,482,367 | 670,431 | SOLE | |||
| 2seventy bio, Inc. | COMMON STOCK | 901384107 | $11,788,323 | 2,497,526 | SOLE |